News

Pro-Pharmaceuticals said that in previous experiments its polysaccharide compounds that target Galectin receptors have been shown to reverse the formation of fibrotic tissue in diseased rat livers. Scott

MorphoSys’s clinical pipeline now comprises nine partnered programs in Phase 1 and five in Phase 2 development as well as the company’s proprietary programs MOR103, which is in

‘081 is a single molecule functioning as both a muscarinic antagonist and a beta2 receptor agonist (MABA). ‘081 is an investigational compound within the inhaled bifunctional muscarinic antagonist-beta2

Merrion claims that its patented drug delivery technology, GIPET, is supported by a large database reflecting 10 years’ research and development by drug delivery experts and 21 clinical

The company said that the new manufacturing unit is expected to be operational in 2015 and requires an investment of EUR250m in two steps. UCB Technical Operations &

Reportedly, the Drug Controller General of India (DCGI) office has directed the state regulatory bodies to begin inspections to take stock of the situation. Out of the 3000

The transaction is expected to provide DSM with new opportunities in the infant nutrition segment as well as food and beverage and dietary supplements. It will also provide

Paracetamol, also known as acetaminophen, is an over-the-counter (OTC) drug used to treat mild to moderate pain from headaches, backaches, osteoarthritis and to reduce fever. Genmed first filed

Ataluren is a protein restoration therapy designed to enable the formation of full-length, functional cystic fibrosis transmembrane regulator (CFTR) protein in patients with cystic fibrosis due to a